Literature DB >> 399315

Hormone therapy and affect.

L Dennerstein, G D Burrows, G J Hyman, K Sharpe.   

Abstract

This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances, and placebo. Affect was measured by the Hamilton Depression Rating Scale, verbal reports by women and self-ratings on visual analogue scales. Ethinyl oestradiol was found to have a beneficial influence on aspects of affect such as Hamilton scores, anxiety irritability and insomnia. The influence of hormones on Hamilton scores could be partly but not fully explained by the alleviation of hot flushes. Norgestrel showed less favourable changes initially but these tended to diminish by the third therapy month. Most of the women studied were not clinically depressed. Anxiety symptoms were the major features exhibited in the group of women investigated. The results of this study suggest that visual analogue rating scales are of questionable validity in assessing affect in patients without any appreciable psychiatric morbidity.

Entities:  

Keywords:  Behavior; Central Nervous System Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Depression--analysis; Diseases; Ethinyl Estradiol; Family Planning; Mental Disorders; Population Characteristics; Psychological Factors

Mesh:

Substances:

Year:  1979        PMID: 399315     DOI: 10.1016/0378-5122(79)90015-x

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  8 in total

1.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 2.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

3.  Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women.

Authors:  A M Fonseca; V R Bagnoli; S R L Penteado; J S Paixão; A L Cavalcanti; J A Pinotti
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.

Authors:  Hayden B Bosworth; Lori A Bastian; Steven C Grambow; Colleen M McBride; Celette Sugg Skinner; Laura Fish; Barbara K Rimer; Ilene C Siegler
Journal:  J Behav Med       Date:  2005-02

Review 5.  Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.

Authors:  A H Maclennan; J L Broadbent; S Lester; V Moore
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 6.  Should symptomatic menopausal women be offered hormone therapy?

Authors:  Rogerio A Lobo; Serge Bélisle; William T Creasman; Nancy R Frankel; Neil F Goodman; Janet E Hall; Susan Lee Ivey; Sheryl Kingsberg; Robert Langer; Rebecca Lehman; Donna Behler McArthur; Valerie Montgomery-Rice; Morris Notelovitz; Gary S Packin; Robert W Rebar; MaryEllen Rousseau; Robert S Schenken; Diane L Schneider; Katherine Sherif; Susan Wysocki
Journal:  MedGenMed       Date:  2006

7.  Postmenopausal estrogen therapy and depressive symptoms in older women.

Authors:  M A Whooley; D Grady; J A Cauley
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

8.  Optimal management of perimenopausal depression.

Authors:  Barbara L Parry
Journal:  Int J Womens Health       Date:  2010-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.